Medical treatment of cardiac arrhythmias.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000404:Ajmaline / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000188:drug therapy; D001282:Atrial Flutter / Q000188:drug therapy; D001919:Bradycardia / Q000188:drug therapy; D004071:Digitalis Glycosides / Q000627:therapeutic use; D006801:Humans; D010672:Phenytoin / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011802:Quinidine / Q000097:blood / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use; D013610:Tachycardia / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D004071:Digitalis Glycosides; D013565:Sympatholytics; D000404:Ajmaline; D010672:Phenytoin; D011802:Quinidine; D011342:Procainamide